Skip to main content
Skip to section navigation
Skip to footer
About Us
Company Overview
Management
Board of Directors
Pipeline
Pipeline Overview
Paxalisib
PD-L1 Protein Degrader
SETDB1 Inhibitor
EVT801
Clinical Trials
Posters & Publications
Technology
Media Center
Media Center Overview
News
Events
In The News
Video Gallery
ASX Announcements
Investors
Investors Overview
News & Events
Company Info
Financial Results
Stock Data
SEC Filings
Governance
ASX Delisting
Contact Us
Video Gallery
Media Center
Media Center
Media Center Overview
News
Events
In The News
Video Gallery
ASX Announcements
Mar 26, 2026
2025 Kazia Therapeutics AGM
May 7, 2024
Kazia Interview with Professor Sudha Rao from QIMR Berghofer Medical Research Institute
Feb 2, 2024
Kazia Interview with Professor Matt Dun from the University of Newcastle, Australia
